Moreover, recent research has shown a pivotal relationship between EGFR overexpression or EGFR amplification and disease progression, poor survival, resistance to chemotherapy, and poor response [23]. EGFR amplification and EGFR overexpression affect 30–50% of adult GBM [24]. This evidence concerns the gene EGFR and glioblastoma.